Breaking News
Get 45% Off 0
It’s Here: WarrenAI - Your Personal Financial AI Researcher >>>
Try WarrenAI Now
Close

Manulife Contrarian Strategy Eq (229002)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.858 +0.028    +1.53%
21/04 - Delayed Data. Currency in CNY
Type:  Fund
Market:  China
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 105.41M
Manulife TEDA Contrarian Strategy Equity Fund 1.858 +0.028 +1.53%

229002 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Manulife TEDA Contrarian Strategy Equity Fund (229002) fund. Our Manulife TEDA Contrarian Strategy Equity Fund portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 2.180 2.180 0.000
Shares 93.180 93.180 0.000
Bonds 5.050 5.050 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 17.169 18.341
Price to Book 2.232 2.452
Price to Sales 1.233 1.935
Price to Cash Flow 9.950 11.671
Dividend Yield 2.004 2.443
5 Years Earnings Growth 13.747 12.540

Sector Allocation

Name  Net % Category Average
Technology 33.520 28.813
Industrials 15.550 22.395
Consumer Cyclical 11.410 13.272
Financial Services 10.390 9.960
Basic Materials 9.330 9.596
Healthcare 8.040 8.490
Consumer Defensive 4.990 9.517
Energy 2.980 5.012
Communication Services 1.480 3.841
Real Estate 1.230 3.140
Utilities 1.080 4.630

Region Allocation

  • Asia
  • Emerging Markets

Top Holdings

Number of long holdings: 212

Number of short holdings: 1

Name ISIN Weight % Last Change %
TREASURY COUPON BOND 2024 21 - 5.05 - -
  Shandong Zhongji Electrical CNE100001CY9 2.80 79.83 -1.68%
  Hygon Information Tech CNE100005PT2 2.71 155.20 +0.96%
  Wus Circuit A CNE100000SP5 2.60 27.65 -1.64%
  Sieyuan Electric A CNE000001KM8 2.46 74.39 0.00%
  GigaDevice Semiconductor CNE1000030S9 2.30 114.14 +1.49%
  T&S Communications CNE100002DR9 1.80 68.17 -1.57%
  Xcmg Machinery A CNE000000FH0 1.78 8.80 -1.57%
  Range Intelligent Computing Tech CNE100001Z58 1.61 53.12 -2.23%
  Hithink RoyalFlush Info Network CNE100000JG3 1.50 265.26 -0.46%

Top Equity Funds by MANULIFE Fund Mgmt Co.,Ltd

  Name Rating Total Assets YTD% 3Y% 10Y%
  Manulife TEDA Trsfmtn Opportunity E 4.23B -2.89 -4.05 8.03
  TEDA Value Optimization Growth Ind 1.38B 1.84 0.03 3.71
  MANULIFE TEDA Market Value Selectio 1.19B -0.66 4.73 1.71
  MANULIFE TEDA RuiZhi WJ Alloc 880.8M 0.93 1.59 -
  MANULIFE TEDA Industry Selected 725.62M 0.67 0.38 4.95
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

229002 Comments

Write your thoughts about Manulife Contrarian Strategy Eq
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email